Halozyme Therapeutics
HALO
#2489
Rank
S$7.82 B
Marketcap
$61.49
Share price
-0.13%
Change (1 day)
18.23%
Change (1 year)

Halozyme Therapeutics (HALO) - Cash on Hand

Cash on Hand as of September 2024 : S$0.89 Billion

According to Halozyme Therapeutics's latest financial reports the company has S$0.89 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.44 B-8.76%
2022-12-31S$0.48 B-51.44%
2021-12-31S$1.00 B105.74%
2020-12-31S$0.48 B-14.28%
2019-12-31S$0.56 B17.26%
2018-12-31S$0.48 B-22.82%
2017-12-31S$0.62 B111.54%
2016-12-31S$0.29 B93.59%
2015-12-31S$0.15 B-14.48%
2014-12-31S$0.17 B97.81%
2013-12-31S$90.59 M-25.55%
2012-12-31S$0.12 B77.86%
2011-12-31S$68.41 M-36.21%
2010-12-31S$0.10 B13.23%
2009-12-31S$94.71 M3.94%
2008-12-31S$91.12 M-35.17%
2007-12-31S$0.14 B107.44%
2006-12-31S$67.76 M112.71%
2005-12-31S$31.85 M21.98%
2004-12-31S$26.11 M2952.3%
2003-12-31S$0.85 M407.04%
2002-12-31S$0.16 M248.88%
2001-12-31S$0.04 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.33 B-62.82%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.73 B 428.05%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.81 B 214.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.39 B 1,393.61%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.80 B 993.21%๐Ÿ‡ซ๐Ÿ‡ท France
S$27.31 B 2,946.20%๐Ÿ‡บ๐Ÿ‡ธ USA